Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma.

Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 17 11 2023
medline: 22 2 2024
pubmed: 22 2 2024
entrez: 22 2 2024
Statut: aheadofprint

Résumé

Not available.

Identifiants

DOI: 10.3324/haematol.2023.284694 PMID: 38385280
pubmed: 38385280
doi: 10.3324/haematol.2023.284694
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Maria Victoria Mateos (MV)

Hospital Universitario de Salamanca, Spain; University of Salamanca. mvmateos@usal.es.

Katja Weisel (K)

University Hospital Hamburg-Eppendorf, Hamburgo.

Evangelos Terpos (E)

National and Kapodistrian University of Athens, Medicine School, Athens, Greece.

Sossana Delimpasi (S)

Evangelismos General Hospital, Athens, Greece.

Efstathios Kastritis (E)

National and Kapodistrian University of Athens, Medicine School, Athens, Greece.

Elena Zamagni (E)

University of Bologna.

Michel Delforge (M)

University Hospital Leuven, Leuven.

Enrique Ocio (E)

Hospital Universitario Marques de Valdecilla (IDIVAL), Santander, Spain; University of Cantabria, Santander, Spain.

Eirini Katodritou (E)

Theageneion Cancer Hospital, Thessaloniki, Greece.

Francesca Gay (F)

University of Torino, Italy; AOU Citta della Salute e della Scienza of Turin.

Alessandra Larocca (A)

University of Torino, Italy; AOU Citta della Salute e della Scienza of Turin.

Xavier Leleu (X)

Hopital La Mileterie.

Paula Rodriguez Otero (PR)

Clinica Universidad de Navarra, Pamplona. Spain; Centro de Investigacion Medica Aplicada (CIMA), Pamplona. Spain; Instituto de Investigacion Sanitaria de Navarra IDISNA, Pamplona. Spain; Centro de Investigacion Biomedica en Red en Cancer (CIBERONC) Pamplona, Spain.

Fredik Schjesvold (F)

Oslo Myeloma Center, Oslo, Norway; Oslo University Hospital, Oslo, Norway; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.

Michele Cavo (M)

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seragnoli", Bologna, Italy; Universita di Bologna, Bologna.

Meletios A Dimopoulos (MA)

National and Kapodistrian University of Athens, Medicine School, Athens, Greece.

Classifications MeSH